In a filing, IGM Biosciences Inc revealed its PRINCIPAL ACCOUNTING OFFICER Weber Steven unloaded Company’s shares for reported $4032.0 on Dec 16 ’24. In the deal valued at $7.48 per share,539 shares were sold. As a result of this transaction, Weber Steven now holds 31,704 shares worth roughly $54213.84.
Then, Decker Lisa Lynn sold 1,063 shares, generating $7,951 in total proceeds. Upon selling the shares at $7.48, the CHIEF BUSINESS OFFICER now owns 78,041 shares.
Before that, Harler Mary Beth sold 1,708 shares. IGM Biosciences Inc shares valued at $12,776 were divested by the Chief Executive Officer at a price of $7.48 per share. As a result of the transaction, Harler Mary Beth now holds 347,032 shares, worth roughly $0.59 million.
Stifel downgraded its IGM Biosciences Inc [IGMS] rating to a Hold from a a Buy in a research note published on January 10, 2025; the price target was decreased to $2.50 from $27. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who decreased its forecast for the stock in early January from “an Outperform” to “a Sector perform”. Morgan Stanley also remained covering IGMS and has decreased its forecast on January 10, 2025 with a “an Underweight” recommendation from previously “an Equal-weight” rating. Guggenheim revised its rating on January 10, 2025. It rated IGMS as “a Neutral” which previously was an “a Buy”.
Price Performance Review of IGMS
On Tuesday, IGM Biosciences Inc [NASDAQ:IGMS] saw its stock fall -3.66% to $1.71. Over the last five days, the stock has lost -73.69%. IGM Biosciences Inc shares have fallen nearly -72.01% since the year began. Nevertheless, the stocks have fallen -84.40% over the past one year. While a 52-week high of $22.50 was reached on 01/07/25, a 52-week low of $1.77 was recorded on 01/14/25. SMA at 50 days reached $9.0922, while 200 days put it at $10.2403.
Levels Of Support And Resistance For IGMS Stock
The 24-hour chart illustrates a support level at 1.6367, which if violated will result in even more drops to 1.5635. On the upside, there is a resistance level at 1.7966. A further resistance level may holdings at 1.8833. The Relative Strength Index (RSI) on the 14-day chart is 17.06, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.5656, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.90%. Stochastics %K at 1.68% indicates the stock is a buying.
How much short interest is there in IGM Biosciences Inc?
A steep rise in short interest was recorded in IGM Biosciences Inc stocks on 2024-12-31, dropping by -0.19 million shares to a total of 2.51 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 2.7 million shares. There was a decline of -7.63%, which implies that there is a negative sentiment for the stock.
